168 related articles for article (PubMed ID: 25063724)
1. Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure.
Ali FN; Falkner B; Gidding SS; Price HE; Keith SW; Langman CB
J Pediatr; 2014 Oct; 165(4):738-43.e1. PubMed ID: 25063724
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor-23 is independently associated with cardiac mass in African-American adolescent males.
Falkner B; Keith SW; Gidding SS; Langman CB
J Am Soc Hypertens; 2017 Aug; 11(8):480-487. PubMed ID: 28456498
[TBL] [Abstract][Full Text] [Related]
3. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
Mitsnefes MM; Betoko A; Schneider MF; Salusky IB; Wolf MS; Jüppner H; Warady BA; Furth SL; Portale AA
Clin J Am Soc Nephrol; 2018 Jan; 13(1):45-52. PubMed ID: 29025789
[TBL] [Abstract][Full Text] [Related]
4. Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.
Sinha MD; Turner C; Booth CJ; Waller S; Rasmussen P; Goldsmith DJ; Simpson JM
Pediatr Nephrol; 2015 Oct; 30(10):1843-52. PubMed ID: 25975437
[TBL] [Abstract][Full Text] [Related]
5. The association of FGF23 levels in obese adolescents with insulin sensitivity.
Wojcik M; Janus D; Dolezal-Oltarzewska K; Drozdz D; Sztefko K; Starzyk JB
J Pediatr Endocrinol Metab; 2012; 25(7-8):687-90. PubMed ID: 23155694
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
[TBL] [Abstract][Full Text] [Related]
7. Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus.
Freedman BI; Divers J; Russell GB; Palmer ND; Bowden DW; Carr JJ; Wagenknecht LE; Hightower RC; Xu J; Smith SC; Langefeld CD; Hruska KA; Register TC
Am J Nephrol; 2015; 42(6):391-401. PubMed ID: 26693712
[TBL] [Abstract][Full Text] [Related]
8. Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure.
Isakova T; Houston J; Santacruz L; Schiavenato E; Somarriba G; Harmon WG; Lipshultz SE; Miller TL; Rusconi PG
Pediatr Nephrol; 2013 Oct; 28(10):2035-42. PubMed ID: 23740037
[TBL] [Abstract][Full Text] [Related]
9. Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults.
Hanks LJ; Casazza K; Judd SE; Jenny NS; Gutiérrez OM
PLoS One; 2015; 10(3):e0122885. PubMed ID: 25811862
[TBL] [Abstract][Full Text] [Related]
10. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
[TBL] [Abstract][Full Text] [Related]
11. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.
Mirza MA; Larsson A; Melhus H; Lind L; Larsson TE
Atherosclerosis; 2009 Dec; 207(2):546-51. PubMed ID: 19524924
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast Growth Factor 23 and Long-Term Cardiac Function: The Multi-Ethnic Study of Atherosclerosis.
Patel RB; Ning H; de Boer IH; Kestenbaum B; Lima JAC; Mehta R; Allen NB; Shah SJ; Lloyd-Jones DM
Circ Cardiovasc Imaging; 2020 Nov; 13(11):e011925. PubMed ID: 33161733
[TBL] [Abstract][Full Text] [Related]
13. Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry.
Eckberg K; Kramer H; Wolf M; Durazo-Arvizu R; Tayo B; Luke A; Cooper R
Nephrol Dial Transplant; 2015 Apr; 30(4):630-5. PubMed ID: 25358495
[TBL] [Abstract][Full Text] [Related]
14. Pre-operative level of FGF23 predicts severe acute kidney injury after heart surgery in children.
Volovelsky O; Terrell TC; Swain H; Bennett MR; Cooper DS; Goldstein SL
Pediatr Nephrol; 2018 Dec; 33(12):2363-2370. PubMed ID: 30022312
[TBL] [Abstract][Full Text] [Related]
15. FGF23 contributes to insulin sensitivity in obese adolescents - preliminary results.
Wojcik M; Dolezal-Oltarzewska K; Janus D; Drozdz D; Sztefko K; Starzyk JB
Clin Endocrinol (Oxf); 2012 Oct; 77(4):537-40. PubMed ID: 22103239
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies.
van der Vaart A; Eelderink C; van Beek AP; Bakker SJL; van Dijk PR; de Borst MH
J Clin Endocrinol Metab; 2023 Sep; 108(10):e971-e978. PubMed ID: 37139691
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults.
Jovanovich A; Ix JH; Gottdiener J; McFann K; Katz R; Kestenbaum B; de Boer IH; Sarnak M; Shlipak MG; Mukamal KJ; Siscovick D; Chonchol M
Atherosclerosis; 2013 Nov; 231(1):114-9. PubMed ID: 24125420
[TBL] [Abstract][Full Text] [Related]
18. Association between circulating fibroblast growth factor-23 and age-related cardiovascular-renal parameters in a healthy Chinese population.
Wang N; Bai X; Jin B; Han W; Sun X; Chen X
Geriatr Gerontol Int; 2017 Aug; 17(8):1221-1231. PubMed ID: 27427468
[TBL] [Abstract][Full Text] [Related]
19. Association between plasma fibroblast growth factor 23 and left ventricular mass index in patients with Takayasu arteritis.
Cheng N; He Y; Dang A; Lv N; Wang X; Li H
Clin Rheumatol; 2020 May; 39(5):1591-1599. PubMed ID: 31897962
[TBL] [Abstract][Full Text] [Related]
20. The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.
Bacchetta J; Dubourg L; Harambat J; Ranchin B; Abou-Jaoude P; Arnaud S; Carlier MC; Richard M; Cochat P
J Clin Endocrinol Metab; 2010 Apr; 95(4):1741-8. PubMed ID: 20157196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
